Skip to main content
. 2018 Nov 19;36(48):7369–7376. doi: 10.1016/j.vaccine.2018.10.021

Table 1.

Characteristics of participating mothers, infants, and children 1–15 years in Karonga District, Malawi in the pre- and post-PCV13 periods.

Pre-PCV13 period (2009–11) Post-PCV13 period (2014) p-value1
Female sex
Infants 6 weeks 35/70 (50.0%) 75/146 (51.4%) 0.97
Infants 18 weeks 33/71 (46.5%) 26/44 (59.1%) 0.26
Children 1–4 years 66/109 (60.6%) 12/29 (41.4%) (unvaccinated) 0.10
15/38 (39.5%) (vaccinated) 0.04
27/74 (36.5%) (all) 0.002
Children 5–15 years 72/144 (50.0%) 40/89 (44.9%) 0.54
HIV-negative mothers 135/135 (100%) 144/144 (100%)



Age in years (mean, sd)
Children 1–4 years 2.7, sd = 0.9 3.5, sd = 0.6 (unvaccinated) <0.001
2.1, sd = 0.7 (vaccinated) <0.001
2.7, sd = 1.0 (all) 0.99
Children 5–15 years 7.8, sd = 2.6 8.5, sd = 3.0 0.002
HIV-negative mothers 26.3, sd = 6.9 24.2, sd = 6.3 <0.001



Number of children <5 years other than the recruited infant (households) 0: 45/166 (27.1%) 0: 79/148 (53.4%)
1: 92/166 (55.4%) 1: 61/148 (41.2%) <0.001
2: 29/166 (17.5%) 2: 8/148(5.4%)

Information included for individuals with at least one sample result.

sd: standard deviation

1

p-values for the comparison between the pre-PCV13 and post-PCV13 period; using the Pearson’s χ2 test for categorical data and the Student’s t-test for numerical data.